TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Unilabs Laboratoriemedisin AS
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover |
152,979
|
173,442
|
162,927 |
Financial expenses |
2,961
|
1,675
|
1,838 |
Earnings before taxes |
4,205
|
9,068
|
22,711 |
Total assets |
113,991
|
135,947
|
98,454 |
Current assets |
45,557
|
60,863
|
52,996 |
Current liabilities |
41,897
|
47,496
|
55,391 |
Equity capital |
35,861
|
32,453
|
25,300 |
- share capital |
358
![]() |
358
![]() |
358 |
Employees (average) | 79 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency |
31.5%
|
23.9%
|
25.7% |
Turnover per employee | 2,195 | ||
Profit as a percentage of turnover |
2.7%
|
5.2%
|
13.9% |
Return on assets (ROA) |
6.3%
|
7.9%
|
24.9% |
Current ratio |
108.7%
|
128.1%
|
95.7% |
Return on equity (ROE) |
11.7%
|
27.9%
|
89.8% |
Change turnover |
-20,463
|
10,515
|
6,074 |
Change turnover % |
-12%
|
6%
|
4% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.